HeraMED Reveals Downturn in Revenue and Steady Loss
Company Announcements

HeraMED Reveals Downturn in Revenue and Steady Loss

HeraMED Ltd. (AU:HMD) has released an update.

HeraMED Limited reported a decrease of 39.3% in revenues to $180,884 and a marginal reduction in loss after tax by 0.7% to $3,212,817 for the half-year ended 30 June 2024, compared to the same period in the previous year. The company’s net tangible assets per share improved to 0.06 cents, and it confirmed that no dividends were paid during this period.

For further insights into AU:HMD stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskHeraMED Ltd. Announces Major ASX Share Quotation
TipRanks Australian Auto-Generated NewsdeskHeraMED Ltd Gains Momentum in Digital Maternity Care
TipRanks Australian Auto-Generated NewsdeskHeraMED Ltd. Announces New Securities Issue Plan
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App